complex that can exhibit a strong PO activity (11) . We also determined the crystal structure of PPAF -II (11) , revealing that the clip domain plays a role by interacting with a protein through its central cleft and is tethered to the SP domain of the protein. 
Crystallization and structure determination -
Crystallization, data collection and phasing of the PPAF-I SP domain were reported (14) . In was used at the final step of refinement (19).
Crystallographic data statistics are summarized in Table I . Structures were superimposed and analyzed out using the function "fitting two molecules" in the program MOLREP (19), and structure presentations were generated using MOLSCRIPT (20) and PYMOL (21) . calcium ion, and 128 water molecules (Fig 2A) .
Activation of PPAF-I by lysyl endopeptidase -
The SP domain of PPAF-I has the conserved core structure of the chymotrypsin fold with the catalytic residues Ser315 (c195;
"c" for the chymotrypsinogen numbering), His155 (c57) and Asp220 (c102) (Fig 2A) . The 
Calcium-binding loop (70-loop)
A three-dimensional modeling study on Drosophila easter predicted that a calcium ion was anchored by Glu193 (c70) and Glu203 (c80) in the 70-loop of easter (24) . The crystal structure of the PPAF-I SP domain showed a complete feature of the calcium ion bound in 70-loop, which is remote from the active-site cleft. In terms of calcium coordination, PPAF-I is different from other calcium-containing SPs including trypsin and PPAF-II ( Fig. 1 and 3A) .
The calcium ion of PPAF-I is hepta- (c72) and Thr180 (c75), plus two water molecules (Fig. 3A) . In particular, Glu175
(c70) and Asp183 (c78) are strictly conserved among easter-type proteases, suggesting the presence of a calcium cage in this family of proteases.
The bound calcium ion in easter has been suggested to play a critical in role in its biological function (24) . Mutation of Glu183
(c70) in easter that abrogates the calcium binding resulted in complete loss of easter activity in Drosophila development when the mRNAs were injected into embryos (24) . Here, we show that the calcium ion is necessary for the enzymatic activity of PPAF-I using a highly purified protein and a calcium-chelating agent. The activated PPAF-I exhibited a significantly decreased enzymatic activity on the chromogenic peptide substrates following addition of EDTA to the reaction buffer (Fig.   3B ). Subsequently, we observed that the proteolytic susceptibility of PPAF-I substantially increased when the bound calcium ion was removed from the protein by EDTA (Fig. 3C) . These results suggest that the calcium ion stabilizes the overall structure of the SP domain leading to enhanced activity, although the calcium ion is not directly involved in the active site, as is the case with trypsin (25) and coagulation factor Xa (26).
A highly protruding activation loop
The activation loop of PPAF-I is highly extended out from the body of the SP domain in the crystal structure, although this region does not show distinct insertion in its primary structure, compared with chymotrypsinogen (Fig 1, 2A and 2B) . Interestingly, the corresponding loop of PPAF-II extends out from the core structure as observed in PPAF-I ( Enteropeptidase, which is known to activate trypsinogen, has a deep active-site cleft (27) .
This led us to speculate that 75-loop might prevent access of the active site cleft of enteropeptidase to the activation loop of PPAF-I, for 75-loop is the nearest structural element to the activation loop (Fig. 5B) .
The canyon-like deep active-site cleft
The structure of the PPAF-I SP domain defines a highly ordered and deep canyon-like activesite cleft. This canyon-like deep active site has been observed in thrombin, which is responsible for the high substrate specificity. (the activation site) was determined by the N-terminus of the corresponding fragments, the cleavage sites 1 and 3 were estimated by the N-terminal and the apparent molecular weight of the fragments on the gel. Note that the band intensities between 3f*, 4f* and 3s*, 4s* are similar on the gel. The N-terminal amino acid sequence of the peptide fragments were determined by an automated gas-phase sequencer (Applied Biosystems). 12.6%
1.3% 0.0% 1 The numbers in parentheses are statistics for the highest resolution shell.
